By Daphne Psaledakis, Simon Lewis and Elias Biryabarema WASHINGTON (Reuters) -About 1,000 doses of Gilead Sciences Inc's drug ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...
The drug lenacapavir will be distributed to Eswatini and Zambia — the first step toward providing at least 2 million doses to ...
Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
Trump administration touts moves to provide HIV prevention drug, but refuses to include South Africa
The US has started to provide doses of a Gilead HIV prevention drug to low-income countries, but the program will not include ...
Deniz Gökengin thinks colleagues view her as “a very serious, hardworking, meticulous, control-freak type of person”. But she ...
The candlelighting ceremony at the World AIDS Day commemorative event. (Photo: PIA Samar) An early World AIDS Day observance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback